Peter Traber
Director/Board Member at Baylor College of Medicine
Net worth: 110 791 $ as of 29/04/2024
Peter Traber active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Baylor College of Medicine | Director/Board Member | 31/12/2007 | - |
| Chief Executive Officer | 31/12/2002 | 31/12/2007 |
Career history of Peter Traber
Former positions of Peter Traber
| Companies | Position | Start | End |
|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 29/03/2020 | 12/11/2023 |
| Alacrita Consulting Ltd. | Corporate Officer/Principal | 30/06/2018 | 31/07/2020 |
| GALECTIN THERAPEUTICS INC. | Director/Board Member | 11/02/2009 | 13/12/2017 |
| Chief Executive Officer | 22/03/2011 | 05/07/2018 | |
| Chief Tech/Sci/R&D Officer | 17/06/2010 | 05/07/2018 | |
| Investor Relations Contact | 11/02/2009 | - | |
| President | 22/03/2011 | 05/07/2018 | |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Director/Board Member | - | 02/08/2007 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 31/12/1999 | 31/12/2002 |
| General Counsel | 31/12/1999 | 31/12/2002 | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | - | - |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | - | - |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Director/Board Member | 21/01/2015 | - |
| Independent Dir/Board Member | 21/01/2015 | - | |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Peter Traber
| University of Michigan | Undergraduate Degree |
| The Wayne State University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 13 |
| United Kingdom | 3 |
Operational
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| President | 3 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 5 |
| Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GALECTIN THERAPEUTICS INC. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 8 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Noble International Ltd.
 Noble International Ltd. Auto Parts: OEMProducer Manufacturing Noble International Ltd. manufactures and supplies automotive components, provides laser welding and cutting services. The company is headquartered in Troy, MI. | Producer Manufacturing |
| Terrasep LLC | |
The University of Pennsylvania Health System
 The University of Pennsylvania Health System Miscellaneous Commercial ServicesCommercial Services The University of Pennsylvania Health System provides general patient care as well as medical education and research services. The company was founded in 1874 and is headquartered in Philadelphia, PA. | Commercial Services |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
| Alacrita Consulting Ltd. | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Peter Traber
- Experience
